Select Publications
Journal articles
2009, 'Investigation of incidental hypercalcaemia', BMJ (Online), 339, pp. 1308 - 1310, http://dx.doi.org/10.1136/bmj.b4613
,2009, 'Global vitamin D status and determinants of hypovitaminosis D (Osteoporosis International DOI:10.1007/s00198-009-0954-6)', Osteoporosis International, 20, pp. 1821, http://dx.doi.org/10.1007/s00198-009-1030-y
,2009, 'Adequacy of Vitamin D Replacement in Severe Deficiency Is Dependent on Body Mass Index', American Journal of Medicine, 122, pp. 1056 - 1060
,2009, 'Common variants in the region around Osterix are associated with bone mineral density and growth in childhood', Human Molecular Genetics, 18, pp. 1510 - 1517
,2009, 'Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis', Journal of Bone and Mineral Research, 24, pp. 294 - 304
,2009, 'Enhancement of Absolute Fracture Risk Prognosis with Genetic Marker: The Collagen I Alpha 1 Gene', Calcified Tissue International, 85, pp. 379 - 388, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19789904
,2009, 'Global vitamin D status and determinants of hypovitaminosis D', Osteoporosis International, 20, pp. 1807 - 1820
,2009, 'Investigation of incidental hypercalcaemia', British Medical Journal, 339, pp. 4613
,2009, 'Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women', JAMA - Journal of the American Medical Association, 301, pp. 513 - 521
,2009, 'Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight', PLoS Clinical Trials, 4, pp. e8415 - e
,2009, 'New sequence variants associated with bone mineral density', Nature Genetics, 41, pp. 15 - 17
,2009, 'Population rates of bone densitometry use in Australia, 2001-2005, by sex and rural versus urban location', Medical Journal of Australia, 190, pp. 126 - 128
,2009, 'Timing of repeat BMD measurements: Development of an absolute risk-based prognostic model', Journal of Bone and Mineral Research, 24, pp. 1800 - 1807
,2009, 'Two-Year Results of Odanacatib (MK-822) Treatment in Postmenopausal Women with Low Bone Mineral Density', Journal of Clinical Densitometry, 12, pp. 395 - 395, http://dx.doi.org/10.1016/j.jocd.2009.03.024
,2009, 'Vitamin D deficiency in critically ill patients', New England Journal of Medicine, 360, pp. 1912 - 1914
,2009, 'Vitamin D deficiency in the intensive care unit: an invisible accomplice to morbidity and mortality?', Intensive Care Medicine, 35, pp. 2028 - 2032
,2008, 'Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis - art. no. 55', BMC Medical Genetics, 9, pp. 55 - 55
,2008, 'Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks', Osteoporosis International, 19, pp. 1431 - 1444
,2008, 'Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study', Journal of Rheumatology, 35, pp. 488 - 497
,2008, 'Endogenous sex hormones and incident fracture risk in older men - The Dubbo Osteoporosis Epidemiology Study', Archives of Internal Medicine, 168, pp. 47 - 54
,2008, 'Endorphins regulate bone homeostasis by actions through dynorphin', Bone, 42, pp. S43 - S44, http://dx.doi.org/10.1016/j.bone.2007.12.070
,2008, 'Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes', Journal of Bone and Mineral Research, 23, pp. 499 - 506, http://dx.doi.org/10.1359/JBMR.071113
,2008, 'Incidence and risk factors for low trauma fractures in men with prostate cancer', Bone, 43, pp. 556 - 560
,2008, 'Multiple genetic loci for bone mineral density and fractures', New England Journal of Medicine, 358, pp. 2355 - 2365
,2008, 'Osteoporosis prevention and treatment in elderly men - a cost-effective strategy', NATURE CLINICAL PRACTICE ENDOCRINOLOGY and METABOLISM, 4, pp. 198 - 199, http://dx.doi.org/10.1038/ncpendmet0753
,2008, 'Pharmacogenetics of osteoporosis and the prospect of individulized prognosis and individulized therapy', Current Opinion in Endocrinology and Diabetes, 15, pp. 481 - 488
,2008, 'Treatment of Paget`s disease of bone: A survey of clinical practice in Australia', Bone, 42, pp. 1219 - 1225, http://dx.doi.org/10.1016/j.bone.2008.01.024
,2007, 'Fourteen years negotiating the polishing and publishing of science', Journal of Bone and Mineral Research, 22, pp. 1829 - 1830, http://dx.doi.org/10.1359/jbmr.0712jae
,2007, 'Challenges in science and academic-industry interactions', Journal of Bone and Mineral Research, 22, pp. 1654 - 1655, http://dx.doi.org/10.1359/jbmr.07090a
,2007, 'Maintaining the trust of physicians and the public in the medical literature: Report of a Task Force on Scientific Publishing of Clinical Trials', Journal of Bone and Mineral Research, 22, pp. 1661 - 1667, http://dx.doi.org/10.1359/jbmr.07090c
,2007, 'The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women', Osteoporosis International, 18, pp. 1033 - 1046, http://dx.doi.org/10.1007/s00198-007-0343-y
,2007, 'Predictive value of BMD for hip and other fractures (Journal of Bone and Mineral Research (2005) 20, (1185-1194))', Journal of Bone and Mineral Research, 22, pp. 774, http://dx.doi.org/10.1359/jbmr.050304e
,2007, 'Predictive value of BMD for hip and other fractures (vol 20, pg 1185, 2005)', JOURNAL OF BONE AND MINERAL RESEARCH, 22, pp. 774 - 774, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000245934000018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Osteoporosis update 1/2007', Osteologie, 16, pp. 53 - 59, http://dx.doi.org/10.1024/1019-1291.16.1.53
,2007, 'Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts', Journal of Clinical Endocrinology and Metabolism, 92, pp. 3599 - 3603
,2007, 'Bone loss and hip fracture: A revisit with time-varying effects', Bone, 40, pp. S140 - S140
,2007, 'Bone loss, weight loss, and weight fluctuation predict mortality risk in elderly men and women', Journal of Bone and Mineral Research, 22, pp. 1147 - 1154
,2007, 'Bone mineral density and hip fracture: A revisit with time-varying effects', Journal of Bone and Mineral Research, 22, pp. S22 - S23
,2007, 'Bone turnover in elderly men: relationships to change in bone mineral density', BMC Musculoskeletal Disorders, 8
,2007, 'Clinical risk factors enhance the performance of BMD in the prediction of fractures', Calcified Tissue International, 80, pp. S29 - S29
,2007, 'Development of a clinical nomogram for individualizing 5-year and 10-year risks of fracture', Bone, 40, pp. S148 - S149
,2007, 'Development of a nomogram for individualizing hip fracture risk in men and women', Osteoporosis International, 18, pp. 1109 - 1117
,2007, 'Discordance of longitudinal changes in bone density between densitometers', Bone, 41, pp. 690 - 697, http://dx.doi.org/10.1016/j.bone.2007.07.002
,2007, 'Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation', Bone, 41, pp. 87 - 96
,2007, 'Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression', The Journal of Biological Chemistry, 282, pp. 19082 - 19091
,2007, 'Intermittent intravenous (i.v.) ibandronate injections are more effective than an established daily oral regimen: DIVA 2-year results', Osteoporosis International, 18, pp. S127 - S127
,2007, 'Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis', The Journal of Biological Chemistry, 282, pp. 19092 - 19102, http://dx.doi.org/10.1074/jbc.M700644200
,2007, 'On the association between statin and fracture: A Bayesian consideration', Bone, 40, pp. 813 - 820
,2007, 'Residual lifetime risk of fractures in women and men', Journal of Bone and Mineral Research, 22, pp. 781 - 788
,2007, 'Risk factors for fracture in nonosteoporotic men and women', Journal of Clinical Endocrinology and Metabolism, 92, pp. 955 - 962
,